AzTrials
AzTrials

DepressionNCT04740411

Online Wellness Intervention for College Students

A study testing The Common Elements Toolbox (COMET) in people with Depression and Anxiety, run by University of Pennsylvania at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

We are evaluating the effects of an online single-session mental health intervention (the Common Elements Toolbox; COMET). To evaluate COMET, we are conducting a randomized controlled trial with college students attending American universities. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Depression, Anxiety, Well-being
What is being tested?
The Common Elements Toolbox (COMET)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
850 participants
Where
1 siteUnited States
Study dates
1 Mar 2021to 1 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • At least 18 years old and a student at a participating university. Access to the internet.

Who cannot join

  • Cannot have participated in a previous version of COMET.

Trial locations and contacts

1 site in 1 country.

Akash Wasil, MA contact

631-766-9466

wasil@sas.upenn.edu

United States1 site, 1 recruiting
  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

    Akash Wasil

    Recruiting

Other trials in United States

About this study

Official title: An Online Wellness Intervention for American College Students: Investigating the Efficacy of The Common Elements Toolbox

We are evaluating the effects of an online single-session mental health intervention (the Common Elements Toolbox; COMET). To evaluate COMET, we are conducting a randomized controlled trial with college students attending American universities. Students will be randomized to the COMET condition or to a wait-list control condition.

Being tested
The Common Elements Toolbox (COMET)
Medical subject headings
Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The Common Elements Toolbox (COMET)Behavioural

    COMET is an online unguided self-help intervention that lasts approximately 60-80 minutes.

Study groups in NCT04740411
Study groupRoleWhat they receive
Common Elements Toolbox (COMET)ExperimentalNot described
Receives: Behavioral: The Common Elements Toolbox (COMET)
Wait-list control conditionNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the Patient Health Questionnaire-9 (PHQ-9)

    Depression questionnaire. Scores range from 0 to 27. Lower scores indicate less depression.

    Measured: Up to 8 weeks post-intervention

  2. Change in the Generalized Anxiety Disorder Screener-7 (GAD-7)

    Anxiety questionnaire. Total scores range from 0-21. Lower scores indicate less anxiety.

    Measured: Up to 8 weeks post-intervention

  3. Change in the Short Warwick-Edinburgh Mental Well-being Scale

    Subjective Well-being questionnaire. Total scores range from 7 to 35. Higher values indicate higher well-being scores.

    Measured: Up to 8 weeks post-intervention

  4. Change in items from the PERMA Profiler (positive emotion and negative emotion subscales).

    Well-being questionnaire with questions related to positive emotion, engagement, relationships, meaning, accomplishment, negative emotion, and health. Scores on each item range from 0 to 5. Lower scores indicate less well-being. We are using a shortened version of this questionnaire with 12 items. We have also modified the items to ask participants about their experiences over the past 48 hours. We predict that our intervention will produce changes in the positive emotion and negative emotion subscales. Each subscale consists of 3 items.

    Measured: Up to 8 weeks post-intervention

Secondary outcomes (12)
  1. Ratings on the Acceptability of Intervention Measure (AIM)

    Questionnaire measuring the acceptability of an intervention. Acceptability refers to the perception that a given treatment is agreeable or satisfactory. The total score ranges from 4 to 20. Higher scores indicate higher acceptability ratings.

    Measured: Immediately after the intervention

  2. Ability to Cope with COVID-19

    2 questions related to their ability to cope with stressors over the past two weeks relating to the COVID-19 pandemic. Participants answered these questions on a 7-point Likert Scale, from "strongly disagree" to "strongly agree". Specifically, we asked participants: a) if they have been able to handle lifestyle changes due to the coronavirus and b) if the pandemic has had an extremely negative impact on their life.

    Measured: Up to 8 weeks post-intervention

  3. Change in Secondary Control

    We administered three items to assess secondary control, derived from the Secondary Control Scale for Children (Weisz et al., 2010). The items are scored on a 4-point Likert scale, ranging from 0 ("Very false") to 3 ("Very true"). Scores on each item range from 0-4, with higher scores indicating more secondary control.

    Measured: Up to 8 weeks post-intervention

  4. Change in the Positive and Negative Affect Schedule

    Questionnaire measuring positive affect and negative affect. Scores on the positive affect subscale range from 10-50, with higher scores representing higher levels of positive affect. Scores on the negative affect subscale range from 10-50, with lower scores representing lower levels of negative affect.

    Measured: Up to 8 weeks post-intervention

  5. Perceived Utility Ratings

    Participants were asked to rate three items relating to the perceived utility of each module. Specifically, we asked participants: How helpful the module was How engaging the module was How much they will continue applying content from the module. Higher scores indicate greater perceived utility.

    Measured: Immediately after the intervention

  6. Change in the Perceived Stress Scale-4

    Questionnaire measuring perceived stress. Scores range from 0-16, with higher scores indicating greater stress.

    Measured: Up to 8 weeks post-intervention

  7. Change in the Gratitude Adjective Checklist

    Gratitude measure. Three items rated on a 1-5 scale with total scores ranging from 3-15. Higher scores indicate higher levels of gratitude.

    Measured: Up to 8 weeks post-intervention

  8. Change in the Self-kindness subscale of the Self-Compassion Scale

    Self-compassion measure. We are using the 5-item self-kindness subscale. Participants will provide values ranging from 1 to 5. These values will be summed to create a total score on this scale ranging from 5 to 25, with higher scores representing higher levels of self-compassion.

    Measured: Up to 8 weeks post-intervention

  9. Change in Cognitive Restructuring

    We administered three items to assess cognitive restructuring, derived from the cognitive reappraisal subscale of the Emotion Regulation Questionnaire. Scores range from 3-21, with higher scores representing a higher amount of cognitive restructuring.

    Measured: Up to 8 weeks post-intervention

  10. Change in items from the Behavioral Activation for Depression Scale

    Behavioral Activation Measure. We selected 3 items from the BADS to use to assess changes in behavioral activation. The scores for these three items are summed to give a total score from 0-18. Higher scores represent higher levels of behavioral activation.

    Measured: Up to 8 weeks post-intervention

  11. Beck Hopelessness Scale

    Hopelessness Questionnaire. Total score ranges from 0 to 4. Higher scores indicate less hope (more hopelessness).

    Measured: Up to 8 weeks post-intervention

  12. Change in module-specific skills

    We are administering 4 items designed to detect cognitive or behavioral changes that relate to each intervention module.

    Cognitive restructuring: "Over the past two weeks, I have been able to manage negative thoughts."

    Behavior activation: "Over the past two weeks, I have intentionally spent time performing hobbies and activities that make me happy."

    Gratitude: "Over the past two weeks, I have been able to focus my attention toward noticing and appreciating good things."

    Self-compassion: "Over the past two weeks, I have been able to treat myself with empathy and compassion."

    For each item, participants respond using a 7-point scale ranging from strongly disagree to strongly agree. Higher scores indicate favorable cognitions and behaviors related to each construct.

    Measured: Up to 8 weeks post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2021
  2. Study start1 Mar 2021
  3. Primary completion1 Mar 2022 (estimated)
  4. Study completion1 Mar 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
850 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04740411
Sponsor's protocol ID
844589
Status last verified
May 2021
First submitted
1 Feb 2021
Last updated
14 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Steinberg JS, Lorenzo-Luaces L, Wasil AR, Howard J, Murphy ST, Strunk DR, DeRubeis RJ. An online wellness intervention for internalizing symptoms in college students: A multi-site randomized controlled trial evaluating the efficacy of the Common Elements Toolbox (COMET). Behav Res Ther. 2026 Aug;203:105074. doi: 10.1016/j.brat.2026.105074. Epub 2026 May 14.

    PubMed 42161216

Questions about this trial

What is this clinical trial studying?

A study testing The Common Elements Toolbox (COMET) in people with Depression and Anxiety, run by University of Pennsylvania at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Akash Wasil, MA (631-766-9466, wasil@sas.upenn.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the Patient Health Questionnaire-9 (PHQ-9) (time frame: Up to 8 weeks post-intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04740411, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2021; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in